Paraguay

Is CBD Legal in Paraguay?

Status

Legal

Covers

CBD

Jurisdiction

Independent Country

Last updated

May 29, 2026

The short answer

CBD is legal in Paraguay for medical and pharmaceutical use under the framework established by Ley 6007/17 and its implementing decrees. DINAVISA (Direccion Nacional de Vigilancia Sanitaria) registers cannabidiol products as controlled medicines requiring prescription. The first domestic CBD medicines were approved in 2019 following the publication of Decreto 9303/18 regulating cannabis-based pharmaceuticals.

Cosmetic and food-grade CBD products are not separately authorized; products imported through Aduanas are screened for medicinal registration. Pharmacies dispense CBD oils for indications including refractory epilepsy, multiple sclerosis spasticity, and chemotherapy-induced nausea. The MSPBS maintains a patient registry. Prices for prescription CBD remain high relative to median wages, and informal imports of US-sourced isolates persist despite the formal channel.

This overview is not legal or medical advice. Patients should consult their physician and a licensed Paraguayan pharmacist; product registration status and prescription rules evolve with each DINAVISA cycle.

Key facts ·

Paraguay

Key facts

Rules at a glance

All countries

THC limit

Pharmaceutical CBD products typically <0.5% THC; medicinal extracts can exceed

Regulator

Direccion Nacional de Vigilancia Sanitaria (DINAVISA); Ministerio de Salud Publica y Bienestar Social (MSPBS)

Key regulation

Ley 6007/17; Decreto 9303/18 reglamentando el uso medicinal del cannabis

Effective

August 21, 2018

Adult-use cannabis

Decriminalized

Medical cannabis

Legal

For brands and importers

Import and export rules

CBD pharmaceuticals may be imported by licensed wholesalers registered with DINAVISA. Paraguay has also licensed domestic producers to export CBD extracts to the EU and Latin American markets under medicinal-cannabis frameworks. Personal import requires a Paraguayan prescription.

FAQ

Common questions

Latest

Latest news and analysis

All news
No items found.